evidencegaps
Primary study · included by 1 review

Topical tacrolimus orabase versus topical clobetasol propionate orabase in the treatment of symptomatic oral lichen planus: a pilot randomized study.

Schroeder 2024 · Schroeder F M M, Pedraça E S, Palma V M, et al. · Clinical oral investigations · 2024

Included by

Evaluating calcineurin inhibitors as alternatives to steroids in treating Oral Lichen Planus: a systematic review and meta-analysis.
Non-Cochrane · intervention · 2026 · cited as Schroeder 2024 · Reference list, ref 35 (included RCT); Supplementary Table S1
Outcome this study informsPooled effectEvidenceCertainty
Pain severity (VAS 0-10)
Topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporin) vs Topical steroids (clobetasol, betamethasone, triamcinolone) · 4 weeks (follow-up weeks 3-4)
MD -0.06 [-0.55, 0.44]5 studies · 276 participantsModerate
Pain severity (VAS 0-10)
Topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporin) vs Topical steroids (clobetasol, betamethasone, triamcinolone) · 4 weeks
MD -0.11 [-0.97, 0.62]5 studies · 275 participantsGRADE not reported

1 including review in total.